Literature DB >> 23611578

In vivo experimental evidence that the major metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency induce oxidative stress in striatum of developing rats: a potential pathophysiological mechanism of striatal damage in this disorder.

Carolina Gonçalves Fernandes1, Mateus Struecker da Rosa, Bianca Seminotti, Paula Pierozan, Rafael Wolter Martell, Valeska Lizzi Lagranha, Estela Natacha Brandt Busanello, Guilhian Leipnitz, Moacir Wajner.   

Abstract

3-Hydroxy-3-methylglutaryl-CoA lyase (HL) deficiency is a genetic disorder biochemically characterized by predominant accumulation of 3-hydroxy-3-methylglutaric (HMG) and 3-methylglutaric (MGA) acids in tissues and biological fluids of affected individuals. Clinically, the patients present neurological symptoms and basal ganglia injury, whose pathomechanisms are partially understood. In the present study, we investigated the ex vivo effects of intrastriatal administration of HMG and MGA on important parameters of oxidative stress in striatum of developing rats. Our results demonstrate that HMG and MGA induce lipid and protein oxidative damage. HMG and MGA also increased 2',7'-dichlorofluorescein oxidation, whereas only HMG elicited nitric oxide production, indicating a role for reactive oxygen (HMG and MGA) and nitrogen (HMG) species in these effects. Regarding the enzymatic antioxidant defenses, both organic acids decreased reduced glutathione concentrations and the activities of superoxide dismutase and glutathione reductase and increased glutathione peroxidase activity. HMG also provoked an increase of catalase activity and a diminution of glucose-6-phosphate dehydrogenase activity. We finally observed that antioxidants fully prevented or attenuated HMG-induced alterations of the oxidative stress parameters, further indicating the participation of reactive species in these effects. We also observed that MK-801, a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, prevented some of these effects, indicating the involvement of the NMDA receptor in HMG effects. The present data provide solid evidence that oxidative stress is induced in vivo by HMG and MGA in rat striatum and it is presumed that this pathomechanism may explain, at least in part, the cerebral alterations observed in HL deficiency.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23611578     DOI: 10.1016/j.ymgme.2013.03.017

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  12 in total

1.  Evidence that 3-hydroxy-3-methylglutaric and 3-methylglutaric acids induce DNA damage in rat striatum.

Authors:  Mateus Struecker da Rosa; Giselli Scaini; Adriani Paganini Damiani; Luiza Martins Longaretti; Maiara Pereira; Bianca Seminotti; Hugo Galvane Zapelini; Patrícia Fernanda Schuck; Emílio Luiz Streck; Vanessa Moraes de Andrade; Moacir Wajner; Guilhian Leipnitz
Journal:  Metab Brain Dis       Date:  2015-05-05       Impact factor: 3.584

Review 2.  Disturbance of redox homeostasis as a contributing underlying pathomechanism of brain and liver alterations in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Authors:  Guilhian Leipnitz; Carmen Regla Vargas; Moacir Wajner
Journal:  J Inherit Metab Dis       Date:  2015-06-04       Impact factor: 4.982

3.  NMDA Receptors and Oxidative Stress Induced by the Major Metabolites Accumulating in HMG Lyase Deficiency Mediate Hypophosphorylation of Cytoskeletal Proteins in Brain From Adolescent Rats: Potential Mechanisms Contributing to the Neuropathology of This Disease.

Authors:  Carolina Gonçalves Fernandes; Paula Pierozan; Gilberto Machado Soares; Fernanda Ferreira; Ângela Zanatta; Alexandre Umpierrez Amaral; Clarissa Günther Borges; Moacir Wajner; Regina Pessoa-Pureur
Journal:  Neurotox Res       Date:  2015-07-15       Impact factor: 3.911

4.  3-Hydroxy-3-Methylglutaric Acid Impairs Redox and Energy Homeostasis, Mitochondrial Dynamics, and Endoplasmic Reticulum-Mitochondria Crosstalk in Rat Brain.

Authors:  Mateus Struecker da Rosa; Nevton Teixeira da Rosa-Junior; Belisa Parmeggiani; Nícolas Manzke Glänzel; Leonardo de Moura Alvorcem; Rafael Teixeira Ribeiro; Mateus Grings; Moacir Wajner; Guilhian Leipnitz
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

5.  Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria.

Authors:  Mariana Dos Santos Mello; Graziela Schmitt Ribas; Carlos Alberto Yasin Wayhs; Tatiane Hammerschmidt; Gilian Batista Balbueno Guerreiro; Jéssica Lamberty Favenzani; Ângela Sitta; Daniella de Moura Coelho; Moacir Wajner; Carmen Regla Vargas
Journal:  Mol Cell Biochem       Date:  2015-01-04       Impact factor: 3.396

6.  CLPB variants associated with autosomal-recessive mitochondrial disorder with cataract, neutropenia, epilepsy, and methylglutaconic aciduria.

Authors:  Carol Saunders; Laurie Smith; Flemming Wibrand; Kirstine Ravn; Peter Bross; Isabelle Thiffault; Mette Christensen; Andrea Atherton; Emily Farrow; Neil Miller; Stephen F Kingsmore; Elsebet Ostergaard
Journal:  Am J Hum Genet       Date:  2015-01-15       Impact factor: 11.025

7.  Induction of a Proinflammatory Response in Cortical Astrocytes by the Major Metabolites Accumulating in HMG-CoA Lyase Deficiency: the Role of ERK Signaling Pathway in Cytokine Release.

Authors:  Carolina Gonçalves Fernandes; Marília Danyelle Nunes Rodrigues; Bianca Seminotti; Ana Laura Colín-González; Abel Santamaria; André Quincozes-Santos; Moacir Wajner
Journal:  Mol Neurobiol       Date:  2015-06-23       Impact factor: 5.590

Review 8.  Role of protein carbonylation in diabetes.

Authors:  Markus Hecker; Andreas H Wagner
Journal:  J Inherit Metab Dis       Date:  2017-11-06       Impact factor: 4.982

9.  3-Hydroxy-3-methylglutaric aciduria with bilateral basal ganglia lesion: A case report.

Authors:  Xiaosheng Hao; Jiangtao Wang; Songyan Liu; Yinbo Chen; Yan Zhang; Yunpeng Hao
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

Review 10.  Neuroketotherapeutics: A modern review of a century-old therapy.

Authors:  Scott J Koppel; Russell H Swerdlow
Journal:  Neurochem Int       Date:  2017-06-01       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.